Rankings
▼
Calendar
LNTH (Lantheus Holdings, Inc.) Stock Financials & Earnings | Market Cap Arena
LNTH
Lantheus Holdings, Inc.
Mkt Cap
$6B
Healthcare
·
Drug Manufacturers - Specialty & Generic
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$1.5B
Net Income (TTM)
$234M
EPS (TTM)
$3.37
Free Cash Flow (TTM)
$349M
Gross Margin
61.1%
Op. Margin
20.2%
Net Margin
15.2%
FCF Margin
22.6%
P/S Ratio (TTM)
3.6x
P/E Ratio (TTM)
23.9x
YoY Rev Growth
+0.5%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$301M
$77M
-$9M
Q2 23
$322M
$203M
$124M
Q3 23
$320M
$200M
$112M
Q4 23
$354M
$230M
$137M
Q1 24
$370M
$252M
$100M
Q2 24
$394M
$256M
$103M
Q3 24
$379M
$242M
$134M
Q4 24
$391M
$249M
$114M
Q1 25
$373M
$238M
$102M
Q2 25
$378M
$241M
$88M
Q3 25
$384M
$222M
$44M
Q4 25
$407M
$241M
$77M
marketcaparena.com
Revenue Breakdown
LNTH
Lantheus Holdings, Inc.
Revenue Breakdown
Q4 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
5.4x
—
Q2 23
5.0x
167.2x
Q3 23
4.6x
53.6x
Q4 23
4.3x
17.1x
Q1 24
4.1x
12.1x
Q2 24
3.9x
13.0x
Q3 24
3.7x
13.0x
Q4 24
3.6x
17.9x
Q1 25
3.6x
21.9x
Q2 25
3.7x
20.6x
Q3 25
3.7x
33.3x
Q4 25
3.6x
23.9x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
$109M
$99M
Q2 23
-$32M
-$43M
Q3 23
$117M
$102M
Q4 23
$112M
$100M
Q1 24
$127M
$119M
Q2 24
$85M
$74M
Q3 24
$175M
$159M
Q4 24
$155M
$139M
Q1 25
$108M
$99M
Q2 25
$87M
$74M
Q3 25
$105M
$95M
Q4 25
$90M
$81M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$9M
Q2 23
$11M
Q3 23
$15M
Q4 23
$12M
Q1 24
$8M
Q2 24
$11M
Q3 24
$16M
Q4 24
$16M
Q1 25
$9M
Q2 25
$13M
Q3 25
$11M
Q4 25
$9M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+44.0%
+106.8%
Q2 23
+43.8%
+23.1%
Q3 23
+33.7%
+35.2%
Q4 23
+34.5%
-50.2%
Q1 24
+23.0%
-13.1%
Q2 24
+22.5%
+47.5%
Q3 24
+18.4%
+18.0%
Q4 24
+10.5%
+28.0%
Q1 25
+0.8%
+0.4%
Q2 25
-4.1%
-0.4%
Q3 25
+1.4%
+38.9%
Q4 25
+4.0%
+18.9%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$10M
3.2%
Q2 23
$0
0.0%
Q3 23
$14M
4.4%
Q4 23
$0
0.0%
Q1 24
$15M
4.2%
Q2 24
$0
0.0%
Q3 24
$0
0.0%
Q4 24
$0
0.0%
Q1 25
$21M
5.7%
Q2 25
$22M
5.9%
Q3 25
$0
0.0%
Q4 25
$0
0.0%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
Quarter
R&D
G&A
S&M
Q1 23
$31M
$23M
$33M
Q2 23
$16M
$26M
$36M
Q3 23
$14M
$36M
$37M
Q4 23
$17M
$40M
$35M
Q1 24
$48M
$48M
$46M
Q2 24
$61M
$47M
$45M
Q3 24
$24M
$41M
$44M
Q4 24
$35M
$58M
$44M
Q1 25
$36M
$57M
$43M
Q2 25
$45M
$67M
$41M
Q3 25
$48M
$82M
$49M
Q4 25
$47M
$70M
$46M
marketcaparena.com
Revenue Segments
Quarter
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$471M
$0
$471M
Q2 23
$414M
$0
$414M
Q3 23
$614M
$0
$614M
Q4 23
$714M
$0
$714M
Q1 24
$718M
$0
$718M
Q2 24
$757M
$0
$757M
Q3 24
$866M
$0
$866M
Q4 24
$913M
$0
$913M
Q1 25
$939M
$0
$939M
Q2 25
$696M
$0
$696M
Q3 25
$382M
$0
$382M
Q4 25
$359M
$0
$359M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
68M
-1.1%
Q2 23
71M
+4.8%
Q3 23
70M
-1.4%
Q4 23
70M
+0.1%
Q1 24
70M
+0.0%
Q2 24
71M
+0.7%
Q3 24
73M
+3.5%
Q4 24
69M
-5.3%
Q1 25
71M
+3.2%
Q2 25
70M
-1.6%
Q3 25
68M
-3.8%
Q4 25
66M
-2.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
—
—
FY 15
$619K
474
FY 16
$649K
465
FY 17
$686K
483
FY 18
$704K
488
FY 19
$684K
508
FY 20
$570K
595
FY 21
$695K
612
FY 22
$1M
698
FY 23
$2M
834
FY 24
$2M
808
FY 25
$8K
200K
marketcaparena.com